Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study

Deepali Kumar, Marian G Michaels, Michele I Morris, Michael Green, Robin K Avery, Catherine Liu, Lara Danziger-Isakov, Valentina Stosor, Michele Estabrook, Soren Gantt, Kieren A Marr, Stanley Martin, Fernanda P Silveira, Raymund R Razonable, Upton D Allen, Marilyn E Levi, G Marshall Lyon, Lorraine E Bell, Shirish Huprikar, Gopi Patel, Kevin S Gregg, Kenneth Pursell, Doug Helmersen, Kathleen G Julian, Kevin Shiley, Bartholomew Bono, Vikas R Dharnidharka, Gelareh Alavi, Jayant S Kalpoe, Shmuel Shoham, Gail E Reid, Atul Humar, American Society of Transplantation H1N1 Collaborative Study Group, Deepali Kumar, Marian G Michaels, Michele I Morris, Michael Green, Robin K Avery, Catherine Liu, Lara Danziger-Isakov, Valentina Stosor, Michele Estabrook, Soren Gantt, Kieren A Marr, Stanley Martin, Fernanda P Silveira, Raymund R Razonable, Upton D Allen, Marilyn E Levi, G Marshall Lyon, Lorraine E Bell, Shirish Huprikar, Gopi Patel, Kevin S Gregg, Kenneth Pursell, Doug Helmersen, Kathleen G Julian, Kevin Shiley, Bartholomew Bono, Vikas R Dharnidharka, Gelareh Alavi, Jayant S Kalpoe, Shmuel Shoham, Gail E Reid, Atul Humar, American Society of Transplantation H1N1 Collaborative Study Group

Abstract

Background: There are few data on the epidemiology and outcomes of influenza infection in recipients of solid-organ transplants. We aimed to establish the outcomes of pandemic influenza A H1N1 and factors leading to severe disease in a cohort of patients who had received transplants.

Methods: We did a multicentre cohort study of adults and children who had received organ transplants with microbiological confirmation of influenza A infection from April to December, 2009. Centres were identified through the American Society of Transplantation Influenza Collaborative Study Group. Demographics, clinical presentation, treatment, and outcomes were assessed. Severity of disease was measured by admission to hospital and intensive care units (ICUs). The data were analysed with descriptive statistics. Proportions were compared by use of chi(2) tests. We used univariate analysis to identify factors leading to pneumonia, admission to hospital, and admission to an ICU. Multivariate analysis was done by use of a stepwise logistic regression model. We analysed deaths with Kaplan-Meier survival analysis.

Findings: We assessed 237 cases of medically attended influenza A H1N1 reported from 26 transplant centres during the study period. Transplant types included kidney, liver, heart, lung, and others. Both adults (154 patients; median age 47 years) and children (83; 9 years) were assessed. Median time from transplant was 3.6 years. 167 (71%) of 237 patients were admitted to hospital. Data on complications were available for 230 patients; 73 (32%) had pneumonia, 37 (16%) were admitted to ICUs, and ten (4%) died. Antiviral treatment was used in 223 (94%) patients (primarily oseltamivir monotherapy). Seven (8%) patients given antiviral drugs within 48 h of symptom onset were admitted to an ICU compared with 28 (22.4%) given antivirals later (p=0.007). Children who received transplants were less likely to present with pneumonia than adults, but rates of admission to hospital and ICU were similar.

Interpretation: Influenza A H1N1 caused substantial morbidity in recipients of solid-organ transplants during the 2009-10 pandemic. Starting antiviral therapy early is associated with clinical benefit as measured by need for ICU admission and mechanical ventilation.

Funding: None.

2010 Elsevier Ltd. All rights reserved.

Figures

Figure
Figure
Date of symptom onset during pandemic

References

    1. Chan M. Swine influenza: statement by WHO Director-General, Dr Margaret Chan. World Health Organization; Geneva: 2009. [accessed June 21, 2010]. .
    1. Kumar A, Zarychanski R, Pinto R, et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA. 2009;2009:1872–79.
    1. Louie JK, Acosta M, Jamieson DJ, Honein MA. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010;2010:27–35.
    1. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature. 2009;2009:931–39.
    1. Danzinger-Isakov L, Kumar D. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant. 2009;9(suppl 4):S258–62.
    1. Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant. 2002;2002:287–91.
    1. Kumar D, Husain S, Chen MH, et al. A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients. Transplantation. 2010;2010:1028–33.
    1. Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis. 2004;2004:1300–06.
    1. Kumar D, Morris MI, Kotton CN, et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant. 2010;2010:18–25.
    1. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. JAMA. 2000;2000:1016–24.
    1. Kumar D, Erdman D, Keshavjee S, et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant. 2005;2005:2031–36.
    1. Malavaud S, Malavaud B, Sandres K, et al. Nosocomial outbreak of influenza virus A (H3N2) infection in a solid organ transplant department. Transplantation. 2001;2001:535–37.
    1. Ljungman P, Andersson J, Aschan JM, et al. Influenza A in immunocompromised patients. Clin Infect Dis. 1993;1993:244–47.
    1. Ison MG, Sharma A, Shepard JA, Wain JC, Ginns LC. Outcome of influenza infection managed with oseltamivir in lung transplant recipients. J Heart Lung Transplant. 2008;2008:282–88.
    1. Jain S, Kamimoto L, Bramley AM, et al. Hospitalized patients with 2009 H1N1 infl uenza in the United States, April–June 2009. N Engl J Med. 2009;361:1935–44.
    1. CDC . Flu activity & surveillance: reports & surveillance methods in the United States. Centers for Disease Control and Prevention; Atlanta, GA: 2010. [accessed June 21, 2010]. .

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere